文献速递乳腺US乳腺X线

随访乳腺超声中增大的BI-RADS 3类病灶:恶性率与需警惕的特征

Growing BI-RADS category 3 lesions on follow-up breast ultrasound: malignancy rates and worrisome features.
PubMed 文献 · Br J Radiol · 2018-04-25

研究随访乳腺超声中增大的BI-RADS 3类病灶的恶性率及相关影像临床特征。在12,514个BI-RADS 3类病灶中,随访增大者占5.9%(738/12,514);有至少24个月随访或病理结果的527个病灶中26个为恶性(4.9%)。超声形态学改变(OR 7.662,p<0.001)和随访乳腺X线出现可疑特征(OR 3.812,p=0.009)与恶性相关;仅增大而无形态学异常或乳腺X线可疑者恶性率仅1.9%。

要点

  • 随访超声增大的BI-RADS 3类病灶恶性率为4.9%(26/527)。
  • 超声形态学改变(OR 7.662)和乳腺X线新出现可疑特征(OR 3.812)与恶性独立相关。
  • 仅增大而无形态学改变且乳腺X线良性者恶性率1.9%,符合继续BI-RADS 3类。

核心结论

  • 随访增大的BI-RADS 3类病灶恶性率为4.9%;超声形态学改变和乳腺X线可疑特征与恶性显著相关;仅前后径增大≤50%且无形态学改变、乳腺X线良性者恶性风险仅1.9%,可推荐随访而非立即活检以减少假阳性活检。

研究设计与样本

  • 研究纳入2010年1月至2011年12月间38,482例乳腺超声检查中的11,582例患者(30.1%)共12,514个BI-RADS 3类病灶,选取随访超声显示病灶增大≥20%者;评估最大径和前后径增大、超声形态学改变、可触及性、多发性、新发肿块、基线乳腺超声指征及乳腺X线BI-RADS分类与恶性的关联,采用多因素分析确定独立预测因子。

诊断标准与关键数值

  • 随访超声显示病灶增大≥20%定义为增大;527个病灶(459例患者)随访至少24个月或有病理结果,其中26个恶性(4.9%);超声形态学改变OR 7.662(p<0.001),随访乳腺X线出现可疑特征OR 3.812(p=0.009);仅增大无超声形态学异常且乳腺X线无可疑特征者恶性率1.9%(BI-RADS 3类)。

临床应用与阅片要点

  • 作者认为,对于前后径增大≤50%且无形态学改变、乳腺X线良性的病灶,可推荐随访而非立即活检,以减少假阳性活检;仅增大而无超声形态学改变者恶性风险1.9%,符合继续BI-RADS 3类分类。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

To determine the frequency and malignancy rate among growing Breast Imaging Reporting and Data System (BI-RADS) category 3 lesions diagnosed on follow-up breast ultrasound and to evaluate the radiological and clinical features associated with malignancy. Methods: Of the 38,482 women who underwent breast ultrasound between January 2010 and December 2011, 11,582 (30.1%) patients had 12,514 BI-RADS category 3 lesions. Patients whose lesions showed ≥20% enlargement on follow-up ultrasound were selected for this study. Radiological and clinical features including increase in the maximum diameter and anteroposterior dimension, morphological changes determined via ultrasound, palpability, multiplicity, new mass, baseline breast ultrasound indication and mammographic BI-RADS category were evaluated to determine their association with malignancy. Multivariate analyses were used to identify independent predictors of malignancy. Results: The frequency of growing BI-RADS category 3 lesions on follow-up ultrasound was 5.9% (738 of 12,514). Of 527 lesions examined in 459 patients with a follow-up duration of at least 24 months or with available pathological results, 26 proved to be malignant (4.9%). Multivariate analyses further indicated that sonographic morphological changes (OR, 7.662, p < 0.001) and development of suspicious features on follow-up mammography (OR, 3.812, p = 0.009) were associated with malignancy. Enlargement without associated suspicious mammography or sonographic morphological abnormalities had only 1.9 % (BI-RADS category 3) chance of malignancy. Conclusion: The malignancy rate for growing BI-RADS category 3 lesions is 4.9%. Sonographic morphological changes and suspicious mammographic features in these tumors are significantly associated with malignancy. Advances in knowledge: For lesions with an interval growth in the anteroposterior dimension of ≤50% without morphological changes, together with a benign mammogram, follow-up rather than an immediate biopsy can be recommended to reduce false-positive biopsy results. The risk of malignancy in lesions with a size increment but with no morphologic change on sonography is only 1.9%, compatible with continued BI-RADS category 3 classification.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Ha SM, Chae EY, Cha JH, et al. Growing BI-RADS category 3 lesions on follow-up breast ultrasound: malignancy rates and worrisome features. Br J Radiol. 2018. PMID: 29658793. doi:10.1259/bjr.20170787

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。